Pfizer Inc. today announced positive results from the Phase 3 BREAKWATER trial evaluating BRAFTOVI® (encorafenib) in combination with cetuximab (marketed as ERBITUX®) and mFOLFOX6 (fluorouracil, ...

Yet in the not-so-distant past, Shapiro didn’t see why the dodo needed to make a comeback. Like many skeptics of the idea of ...

Emerging artist Brandon Morris debuts six phantasmic fiberglass dresses in "Actress" at New York's Europa Gallery.